A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
Mayo Clinic
Mayo Clinic
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
UNC Lineberger Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Canadian Cancer Trials Group
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
Sanford Health
University of Michigan Rogel Cancer Center
University of Utah
Mayo Clinic
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Arizona
University of California, San Francisco
UNC Lineberger Comprehensive Cancer Center
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
Celldex Therapeutics
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
MedImmune LLC
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Henry Ford Health System
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Intuitive Surgical
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine
Radiation Therapy Oncology Group
University of Maryland, Baltimore
Stanford University
University of Iowa
University of Iowa
Butler Hospital
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Northwell Health
University of Kansas Medical Center
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute